Showing results (161-170 of 177) with videos related to
Sort By:
Pageof 18
Plos One|April 18, 2019
Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boostingCheng Cheng, Kai Xu, Rui Kong, et al.Science Translational Medicine|January 17, 2024
Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challengeAmarendra Pegu, Sarah E Lovelace, Megan E DeMouth, et al.Cell Reports|May 31, 2024
Cholesterol reduction by immunization with a PCSK9 mimicBaoshan Zhang, Gwo-Yu Chuang, Andrea Biju, et al.Nature Microbiology|November 1, 2025
Prefusion structure, evasion and neutralization of HSV-1 glycoprotein BRyan S Roark, Andrew J Schaub, Wei Shi, et al.Proceedings of the National Academy of Sciences of the United States of America|November 14, 2018
Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4Guillaume B E Stewart-Jones, Gwo-Yu Chuang, Kai Xu, et al.The Journal of Experimental Medicine|June 23, 2022
Highly protective antimalarial antibodies via precision library generation and yeast display screeningBailey B Banach, Prabhanshu Tripathi, Lais Da Silva Pereira, et al.Cell Reports|April 7, 2021
Fusion peptide priming reduces immune responses to HIV-1 envelope trimer baseAngela R Corrigan, Hongying Duan, Cheng Cheng, et al.Immunity|November 17, 2021
Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodiesSven Kratochvil, Chen-Hsiang Shen, Ying-Cing Lin, et al.Cell Reports|August 7, 2020
Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell SignatureCheng Cheng, Hongying Duan, Kai Xu, et al.Scientific Reports|February 22, 2020
Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine ImmunogenLi Ou, Wing-Pui Kong, Gwo-Yu Chuang, et al.Pageof 18